TNBC is the most aggressive type of breast cancer, characterized by the absence of estrogen receptor (ER) and progesterone receptor (PR) expression, and lack of human epidermal growth factor receptor 2 (HER2) amplification [1,2,3,4]. This evidence concerns the gene ESR1 and breast cancer.